Influence of human genetic variants on resistance and immunity against malaria;Einfluss genetischer Varianten des Menschen auf Resistenz und Immunität gegen Malaria

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 47, Issue 10, 2004, Pages 1000-1008

  May, J ^a   Horstmann, R ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Balanced polymorphism; Candidate gene; Plasmodium falciparum; Single nucleotide polymorphism

Indexed keywords

GLYCOPHORIN; HEMOGLOBIN; HEMOGLOBIN S; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ALPHA THALASSEMIA; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALARIA FALCIPARUM; REVIEW;

ALPHA-THALASSEMIA; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GLYCOPHORIN; HEMOGLOBIN, SICKLE; HEMOGLOBINS; HUMANS; IMMUNITY, NATURAL; MALARIA, FALCIPARUM; NITRIC OXIDE SYNTHASE; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 16544371134     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-004-0909-1     Document Type: Article

References (50)

1. Miller LH, Baruch DI, Marsh K, Doumbo O.K. (2002) The pathogenic basis of malaria. Nature 415: 673-679
2. Miller LH (1996) Protective selective pressure. Nature 383: 480-481
3. Haldane JBS (1949) The rate of mutation of human genes. Hereditas 35: 267-273
4. Lander ES, Schork N.J. (1994) Genetic dissection of complex traits. Science 265: 2037-2048
5. Rihet P, Traore Y, Abel L et al. (1998) Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 63: 498-505
6. Min-Oo G., Fortin A, Tam MF et al. (2003) Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 35: 357-362
7. Silvie O, Rubinstein E, Franetich JF et al. (2003) Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 9: 93-96
8. Miller LH (1994) Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci USA 91: 2415-2419
9. Sim BKL, Chitnis CE, Wasniowska K et al. (1994) Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264: 1941-1944
10. Maier AG, Duraisingh MT, Reeder JC et al. (2003) Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 9: 87-92
11. Jarolim P, Palek J, Amato D et al. (1991) Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci USA 88: 11022-11026
12. Genton B, al-Yaman F, Mgone CS et al. (1995) Ovalocytosis and cerebral malaria. Nature 378: 564-565
13. Patel SS, Mehlotra RK, Kastens W et al. (2001) The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood 98: 3489-3491
14. Flint J, Harding RM, Boyce A.J., Clegg J.B. (1998) The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 11: 1-51
15. Shear HL, Grinberg L, Gilman J et al. (1998) Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 92: 2520-2526
16. Allen SJ, O'Donnell A, Alexander ND et al. (1997) alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 94: 14736-14741
17. Modiano D, Luoni G, Sirima BS et al. (2001) Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414: 305-308
18. Roth E Jr, Schulman S., Chaventre A et al. (1991) Growth of Plasmodium falciparum inhibited by HbD-Ouled-Rabah. Lancet 337: 742-743
19. Chotivanich K, Udomsangpetch R, Pattanapanyasat K et al. (2002) Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood 100: 1172-1176
20. Hutagalung R, Wilairatana P, Looareesuwan S et al. (1999) Influence of hemoglobin E trait on the severity of Falciparum malaria. J Infect Dis 179: 283-286
21. Beutler E (1994) G6PD deficiency. Blood 84: 3613-3636
22. Bienzle U, Ayeni O, Lucas A.O., Luzzatto L. (1972) Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet 1: 107-110
23. Ruwende C, Khoo SC, Snow RW et al. (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246-249
24. Sherman IW (2003) Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect 5: 897-909
25. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314
26. Hatabu T, Kawazu S, Aikawa M., Kano S. (2003) Binding of Plasmodium falciparum-infected erythrocytes to the membrane-bound form of Fractalkine/CX3CL1. Proc Natl Acad Sci USA 100: 15942-15946
27. Aitman TJ, Cooper LD, Norsworthy PJ et al. (2000) Malaria susceptibility and CD36 mutation. Nature 405: 1015-1016
28. Pain A, Urban BC, Kai O et al. (2001) A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357: 1502-1503
29. Omi K, Ohashi J, Patarapotikul J et al. (2003) CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet 72: 364-374
30. Craig A, Hastings I, Pain A., Roberts D.J. (2001) Genetics and malaria - more questions than answers. Trends Parasitol 17: 55-56
31. Malaguarnera L, Musumeci S. (2002) The immune response to Plasmodium falciparum malaria. Lancet Infect Dis 2: 472-478
32. Hill AV, Allsopp CE, Kwiatkowski D et al. (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595-600
33. *0501- restricted Th1-type immune responses to a Plasmodium falciparum liver stage antigen protect from anaemia in malarial infection. J Infect Dis 183: 168-172
34. Plebanski M, Proudfoot O, Pouniotis D et al. (2002) Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. J Clin Invest 110: 295-301
35. Angulo I, Fresno M. (2002) Cytokines in the pathognesis of and protection against malaria. Clin Diagn Lab Immunol 9: 1145-1152
36. McGuire W, Hill AV, Allsopp CE et al. (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510
37. Knight JC, Udalova I, Hill AV et al. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 22: 145-150
38. Ubalee R, Suzuki F, Kikuchi M et al. (2001) Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar. Tissue Antigens 58: 407-410
39. Plebanski M, Hill A.V. (2000) The immunology of malaria infection. Curr Opin Immunol 12: 437-441
40. May J, Lell B, Luty A et al. (2000) Plasma Interleukin 10: Tumor necrosis factor (TNF) ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 182: 1570-1573
41. Koch O, Awomoyi A, Usen S et al. (2002) IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J Infect Dis 185: 1684-1687
42. Luoni G, Verra F, Arca B et al. (2001) Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun 2: 411-414
43. Morahan G, Boutlis CS, Huang D et al. (2002) A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun 3: 414-418
44. Good MF, Doolan D.L. (1999) Immune effector mechanisms in malaria. Curr Opin Immunol 11: 412-419
45. Kun JF, Mordmuller B, Lell B et al. (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351: 265-266
46. Burgner D, Xu W, Rockett K et al. (1998) Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 352: 1193-1194
47. Luty AJ, Kun JF, Kremsner P.G. (1998) Mannosebinding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 178: 1221-1224
48. Cockburn IA, Mackinnon MJ, O'Donnell A et al. (2004) A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci USA 101: 272-277
49. Cooke GS, Aucan C, Walley AJ et al. (2003) Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg 69: 565-568
50. Omi K, Ohashi J, Patarapotikul J et al. (2002) Fcgamma receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol Int 51: 361-366